KERRY GROUP PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 79.05 EUR | 0.00% |
|
-1.62% | +0.50% |
| Apr. 02 | Bernstein starts AstraZeneca at 'outperform' | AN |
| Feb. 22 | Transcript : Kerry Group plc Presents at 2024 Consumer Analyst Group of New York Conference, Feb-22-2024 10:00 AM |
| Sales 2024 * | 7.99B 8.51B | Sales 2025 * | 8.49B 9.03B | Capitalization | 13.76B 14.65B |
|---|---|---|---|---|---|
| Net income 2024 * | 720M 766M | Net income 2025 * | 827M 880M | EV / Sales 2024 * | 1.92 x |
| Net Debt 2024 * | 1.55B 1.65B | Net Debt 2025 * | 1.08B 1.14B | EV / Sales 2025 * | 1.75 x |
| P/E ratio 2024 * |
18.9
x | P/E ratio 2025 * |
16.3
x | Employees | 21,000 |
| Yield 2024 * |
1.6% | Yield 2025 * |
1.76% | Free-Float | 88.33% |
More Fundamentals
* Assessed data
More news
Latest transcript on Kerry Group plc
| 1 week | +0.06% | ||
| Current month | -0.49% | ||
| 1 month | -3.81% | ||
| 3 months | +2.77% | ||
| 6 months | +6.31% | ||
| Current year | +0.50% |
1 week
78.65
81.55
1 month
76.9582.46
Current year
75.4083.34
1 year
71.08100.00
3 years
71.08130.00
5 years
71.08130.00
10 years
49.31130.00
| Managers | Title | Age | Since |
|---|---|---|---|
Edmond Scanlon
CEO | Chief Executive Officer | 50 | 17-01-31 |
| Director of Finance/CFO | 53 | 88-12-31 | |
Gerry Behan
PSD | President | 59 | 08-05-12 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Mike Kerr
BRD | Director/Board Member | 64 | 21-05-02 |
| Director/Board Member | 64 | 18-05-07 | |
Jin Long Wang
BRD | Director/Board Member | 67 | 21-01-04 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.53% | 10 M€ | +6.14% | - | |
| 1.11% | 49 M€ | +3.62% | ||
| 0.97% | 12 M€ | +15.09% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-18 | 79.05 | 0.00% | 235,508 |
| 24-04-17 | 79.05 | -0.25% | 519,852 |
| 24-04-16 | 79.25 | -0.81% | 484,397 |
| 24-04-15 | 79.9 | -0.75% | 563,919 |
| 24-04-12 | 80.5 | +0.19% | 579,999 |
Real-time Irish S.E., April 18, 2024 at 11:55 am EDT
More quotes
Kerry Group plc is a world leading taste and nutrition partner for the food, beverage and pharmaceutical markets. It innovates with its customers to create great tasting products, with improved nutrition and functionality, while ensuring better impact for the planet. Net sales break down by family of products as follows:
- tastes and nutritional ingredients (86.5%);
- dairy ingredients and products (13.5%; Dairy Ireland): primarily functional proteins, nutritional bases and chilled dairy.
At the end of 2023, the group had 137 production sites worldwide.
Net sales are distributed geographically as follows: Ireland (6.7%), Europe (24.7%), Americas (47.4%) and Asia/Pacific/Middle East/Africa (21.1%).
Sector
Food Processing
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
79.05
EUR
Average target price
96.59
EUR
Spread / Average Target
+22.19%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +0.50% | 14.6B | |
| -4.38% | 268B | |
| -7.26% | 89.46B | |
| +0.35% | 44.86B | |
| +0.65% | 39.98B | |
| +6.06% | 38.68B | |
| -0.85% | 37.26B | |
| -14.54% | 30.32B | |
| -7.40% | 29.36B | |
| -9.38% | 22.66B |
- Stock Market
- Equities
- KRZ Stock
